Changes in disease pattern and treatment outcome of colorectal cancer: A review of 5,474 cases in 20 years

International Journal of Colorectal Disease

Volumn 22, Issue 8, 2007, Pages 855-862

  Ju, Jiun Ho ^a   Chang, Shih Ching ^a   Wang, Huann Shen ^a   Yang, Shung Haur ^a   Jiang, Jen Kae ^a   Chen, Wei Chone ^a   Lin, Tzu Chen ^a   Hsu, Hung ^a   Wang, Feng Ming ^a   Lin, Jen Kou ^a,b  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b NONE   (Taiwan)

Author keywords

Colorectal cancer; Prognosis; Treatment

Indexed keywords

ANTINEOPLASTIC AGENT; CARCINOEMBRYONIC ANTIGEN;

ADULT; AGED; ANASTOMOSIS LEAKAGE; CANCER CHEMOTHERAPY; CANCER GRADING; CANCER STAGING; CLINICAL FEATURE; COLON CANCER; COLORECTAL CANCER; COLORECTAL SURGERY; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DISEASE SURVEILLANCE; FEMALE; HUMAN; LONG TERM CARE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MORBIDITY; ONSET AGE; OUTCOME ASSESSMENT; OUTCOMES RESEARCH; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; RECTUM CANCER; RECURRENT CANCER; REVIEW; SURGICAL MORTALITY; SURGICAL TECHNIQUE; SURVIVAL RATE; TREATMENT DURATION; TREND STUDY;

AGE OF ONSET; AGED; ANTINEOPLASTIC AGENTS; CARCINOEMBRYONIC ANTIGEN; CELL DIFFERENTIATION; COLORECTAL NEOPLASMS; COMBINED MODALITY THERAPY; DIGESTIVE SYSTEM SURGICAL PROCEDURES; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; KAPLAN-MEIERS ESTIMATE; MALE; MEDICAL RECORDS SYSTEMS, COMPUTERIZED; MIDDLE AGED; NEOPLASM STAGING; PROPORTIONAL HAZARDS MODELS; QUALITY OF LIFE; RECURRENCE; TAIWAN; TIME FACTORS; TREATMENT OUTCOME;

EID: 34250757036     PISSN: 01791958     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00384-007-0293-z     Document Type: Review

References (44)

1. Weitz J, Koch M, Debus J et al (2005) Colorectal cancer. Lancet 365:153-165
2. Health and Vital Statistics (2000) Department of Health, ROC, Taipei
3. Compton CC, Fielding LP, Burgart LJ et al (2000) Prognostic factors in colorectal cancer. College of American Pathologists Consensus Statement 1999. Arch Pathol Lab Med 124:979-994
4. Gill S, Loprinzi CL, Sargent DJ et al (2004) Pooled analysis of fluorouracil-based adjuvant therapy for stage II and III colon cancer: who benefits and by how much? J Clin Oncol 22:1797-1806
5. Marsoni S, International Multicenter Pooled Analysis of Colon Cancer Trials Investigators (2001) Efficacy of adjuvant fluorouracil and leucovorin in stage B2 and C colon cancer. International Multicenter Pooled Analysis of Colon Cancer Trials Investigators. Semin Oncol 28:14-19
6. Dahlberg M, Pahlman L, Bergstrom R et al (1998) Improved survival in patients with rectal cancer: A population-based register study. Br J Surg 85:515-520
7. Enker WE, Thaler HT, Cranor ML et al (1995) Total mesorectal excision in the operative treatment of carcinoma of the rectum. J Am Coll Surg 181:335-346
8. Zhao GP, Zhou ZG, Lei WZ et al (2005) Pathological study of distal mesorectal cancer spread to determine a proper distal resection margin. World J Gastroenterol 11:319-322
9. Rullier E, Laurent C, Bretagnol F et al (2005) Sphincter-saving resection for all rectal carcinomas: The end of the 2-cm distal rule. Ann Surg 241:465-469
10. Schiessel R, Novi G, Holzer B et al (2005) Technique and long-term results of intersphincteric resection for low rectal cancer. Dis Colon Rectum 48:1858-1865 (discussion 1865-1867)
11. American Joint Committee on Cancer (1997) AJCC cancer staging manual, 5th edn. Springer, Berlin Heidelberg New York
12. Mostafa G, Matthews BD, Norton HJ et al (2004) Influence of demographics on colorectal cancer. Am Surg 70:259-264
13. Mensink PB, Kolkman JJ, Van Baarlen J et al (2002) Change in anatomic distribution and incidence of colorectal carcinoma over a period of 15 years: Clinical considerations. Dis Colon Rectum 45:1393-1396
14. Takada H, Ohsawa T, Iwamoto S et al (2002) Changing site distribution of colorectal cancer in Japan. Dis Colon Rectum 45:1249-1254
15. Newcomb PA, Norfleet RG, Storer BE et al (1992) Screening sigmoidoscopy and colorectal cancer mortality. J Natl Cancer Inst 84:1572-1575
16. Selby JV, Friedman GD, Quesenberry CP Jr et al (1992) A case-control study of screening sigmoidoscopy and mortality from colorectal cancer. N Engl J Med 326:653-657
17. Ransohoff DF, Lang CA (1993) Sigmoidoscopic screening in the 1990s. JAMA 269:1278-1281
18. Williams NS, Dixon MF, Johnston D (1983) Reappraisal of the 5 centimetre rule of distal excision for carcinoma of the rectum: A study of distal intramural spread and of patients' survival. Br J Surg 70:150-154
19. Kameda K, Furusawa M, Mori M et al (1990) Proposed distal margin for resection of rectal cancer. Jpn J Cancer Res 81:100-104
20. Simstein NL, Kovalcik PJ, Cross GH (1978) Colorectal carcinoma in patients less than 40 years old. Dis Colon Rectum 21:169-171
21. Qing SH, Rao KY, Jiang HY et al (2003) Racial differences in the anatomical distribution of colorectal cancer: A study of differences between American and Chinese patients. World J Gastroenterol 9:721-725
22. Marble K, Banerjee S, Greenwald L (1992) Colorectal carcinoma in young patients. J Surg Oncol 51:179-182
23. Faivre-Finn C, Bouvier-Benhamiche AM, Phelip JM et al (2002) Colon cancer in France: Evidence for improvement in management and survival. Gut 51:60-64
24. Finn-Faivre C, Maurel J, Benhamiche AM et al (1999) Evidence of improving survival of patients with rectal cancer in France: A population based study. Gut 44:377-381
25. Porter GA, Soskolne CL, Yakimets WW et al (1998) Surgeon-related factors and outcome in rectal cancer. Ann Surg 227:157-167
26. Smith JA, King PM, Lane RH et al (2003) Evidence of the effect of 'specialization' on the management, surgical outcome and survival from colorectal cancer in Wessex. Br J Surg 90:583-592
27. Scott KW, Grace RH (1989) Detection of lymph node metastases in colorectal carcinoma before and after fat clearance. Br J Surg 76:1165-1167
28. Maurel J, Launoy G, Grosclaude P et al (1998) Lymph node harvest reporting in patients with carcinoma of the large bowel: A French population-based study. Cancer 82:1482-1486
29. Shen M-Y, Lin J-K, Lin T-C et al (2003) Prognostic significance of lymph node metastasis in resected colorectal cancer. J Soc Colon Rectal Surgeon (Taiwan) 14:7-14
30. Buroker TR, O'Connell MJ, Wieand HS et al (1994) Randomized comparison of two schedules of fluorouracil and leucovorin in the treatment of advanced colorectal cancer. J Clin Oncol 12:14-20
31. Francini G, Petrioli R, Lorenzini L et al (1994) Folinic acid and 5-fluorouracil as adjuvant chemotherapy in colon cancer. Gastroenterology 106:899-906
32. Moertel CG (1994) Chemotherapy for colorectal cancer. N Engl J Med 330:1136-1142
33. Moertel CG, Fleming TR, Macdonald JS et al (1990) Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma. N Engl J Med 322:352-358
34. Arkenau HT, Bermann A, Rettig K et al (2003) 5-Fluorouracil plus leucovorin is an effective adjuvant chemotherapy in curatively resected stage III colon cancer: Long-term follow-up results of the adjCCA-01 trial. Ann Oncol 14:395-399
35. Sargent DJ, Goldberg RM, Jacobson SD et al (2001) A pooled analysis of adjuvant chemotherapy for resected colon cancer in elderly patients. N Engl J Med 345:1091-1097
36. Potosky AL, Harlan LC, Kaplan RS et al (2002) Age, sex, and racial differences in the use of standard adjuvant therapy for colorectal cancer. J Clin Oncol 20:1192-1202
37. Ayanian JZ, Zaslavsky AM, Fuchs CS et al (2003) Use of adjuvant chemotherapy and radiation therapy for colorectal cancer in a population-based cohort. J Clin Oncol 21:1293-1300
38. Fata F, Mirza A, Craig G et al (2002) Efficacy and toxicity of adjuvant chemotherapy in elderly patients with colon carcinoma: A 10-year experience of the Geisinger Medical Center. Cancer 94:1931-1938
39. Iwashyna TJ, Lamont EB (2002) Effectiveness of adjuvant fluorouracil in clinical practice: A population-based cohort study of elderly patients with stage III colon cancer. J Clin Oncol 20:3992-3998
40. Jessup JM, Stewart A, Greene FL et al (2005) Adjuvant chemotherapy for stage III colon cancer: Implications of race/ethnicity, age, and differentiation. JAMA 294:2703-2711
41. Fernando NH, Hurwitz HI (2003) Inhibition of vascular endothelial growth factor in the treatment of colorectal cancer. Semin Oncol 30:39-50
42. O'Dwyer PJ, Benson AB 3rd (2002) Epidermal growth factor receptor-targeted therapy in colorectal cancer. Semin Oncol 29:10-17
43. Kitisin K, Mishra L (2006) Molecular biology of colorectal cancer: New targets. Semin Oncol 33(Suppl 11):14-23
44. Wilson RH (2006) Novel therapeutic developments other than EGFR and VEGF inhibition in colorectal cancer. Oncologist 11:1018-1024